Results 151 to 160 of about 596,348 (255)
Machine Learning Techniques in Chronic Kidney Diseases: A Comparative Study of Classification Model Performance. [PDF]
Phuong ND +4 more
europepmc +1 more source
Nanoemulsion delivery of a TLR7 agonist enhances safety and promotes colocalization with Leishmania‐infected macrophages in skin lesions, enabling a ∼2‐log reduction in parasite burden. However, tissue‐level constraints and TLR‐driven regulatory feedback generate a mixed immune response that limits complete parasite clearance.
Carmen Palomino‐Cano +11 more
wiley +1 more source
Tubulointerstitial injury in proteinuric chronic kidney diseases. [PDF]
Cortinovis M, Perico N, Remuzzi G.
europepmc +1 more source
Efficient recovery from traumatic or degenerative diseases is a great challenge, even after all the advancements in bone and cartilage regeneration. Machine learning (ML) algorithms have presented opportunities to enhance these aspects by accurately analyzing imaging data.
Maryam Kamaei +9 more
wiley +1 more source
Prevalence of chronic kidney diseases among people living with HIV in Ethiopia: a systematic review and meta-analysis. [PDF]
Eshetu B +11 more
europepmc +1 more source
An ionic naphthalimide AIE photosensitizer (PS), TPAPV‐NIM‐M, anchors to cellular and bacterial membranes, emits in the far‐red/near‐infrared (NIR) region, and efficiently generates reactive oxygen species (ROS) under white light. Its membrane‐localized photodynamic action drives apoptosis/ferroptosis‐mediated tumor suppression and broad‐spectrum ...
Sayed Mir Sayed +3 more
wiley +1 more source
Potential New Treatments for Chronic Kidney Diseases: A Concise Review. [PDF]
Al-Horani RA.
europepmc +1 more source
The role of N-methyladenosine modification in acute and chronic kidney diseases. [PDF]
Qi S, Song J, Chen L, Weng H.
europepmc +1 more source
Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa +3 more
wiley +1 more source
Prospective association of estimated cardiorespiratory fitness and risk of chronic kidney diseases. [PDF]
Cheng J, Bu C, Zheng X.
europepmc +1 more source

